Structure-activity studies with somatostatin: role of lysine in positions 4 and 9 for gastric activity

[1]  D. Veber,et al.  Somatostatin analogs which define the role of the lysine-9 amino group. , 2009, International journal of peptide and protein research.

[2]  B. Hirst,et al.  Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity , 1984, Peptides.

[3]  O. Rorstad,et al.  Somatostatin analogs: correlation between receptor binding affinity and biological potency in GH pituitary cells. , 1983, Endocrinology.

[4]  D. Coy,et al.  Position 4 substituted somatostatin analogs: increased binding to somatostatin receptors in pituitary and brain. , 1983, Life sciences.

[5]  B. Hirst,et al.  Comparison of the gastric exocrine inhibitory activities and plasma kinetics of somatostatin-28 and somatostatin-14 in cats , 1982, Regulatory Peptides.

[6]  D. Coy,et al.  Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs. , 1981, Endocrinology.

[7]  B. Shaw,et al.  Structure-activity studies with somatostatin: The role of tryptophan in position 8 , 1980, Regulatory Peptides.

[8]  J. Morley,et al.  Non-reducible cyclic, and azaphenylalanyl6 analogues of somatostatin. , 1980, European journal of pharmacology.

[9]  B. Hirst,et al.  Structure‐activity relationships of eighteen somatostatin analogues on gastric secretion. , 1978, The Journal of physiology.

[10]  A. Schally,et al.  [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[11]  W. Vale,et al.  Hypothalamic Hypophysiotropic Hormones , 1975 .